These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28093228)

  • 1. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
    Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
    Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
    Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
    Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
    Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L; Xie Y; Zhang H; Wu Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
    Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
    Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.
    Zhou B; Tang Z; Deng Y; Hou S; Liu N; Lin W; Liu X; Yao L
    Mol Med Rep; 2014 Aug; 10(2):891-6. PubMed ID: 24840052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of NDRG2 in gastric cancer and its clinical significance.
    Chang X; Li Z; Ma J; Deng P; Zhang S; Zhi Y; Chen J; Dai D
    Dig Dis Sci; 2013 Mar; 58(3):715-23. PubMed ID: 23010743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
    Kloten V; Schlensog M; Eschenbruch J; Gasthaus J; Tiedemann J; Mijnes J; Heide T; Braunschweig T; Knüchel R; Dahl E
    PLoS One; 2016; 11(7):e0159073. PubMed ID: 27400234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
    Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
    Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
    Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
    Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.